Economic cost of illicit drug studies: critique and research agenda.
Sindelar
J L
JL
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510.
D015984:Causality; D015897:Comorbidity; D015986:Confounding Factors, Epidemiologic; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D017048:Health Care Costs / Q000706:statistics & numerical data*; D015276:Health Care Rationing / Q000706:statistics & numerical data; D005102:Health Expenditures / Q000706:statistics & numerical data; D006801:Humans; D009937:Organizational Objectives; D012106:Research / Q000458:organization & administration / Q000592:standards*; D012107:Research Design; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000191:economics* / Q000453:epidemiology; D013660:Taxes